1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
(
- Contribution to journal › Article
- 2020
-
Mark
Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
(
- Contribution to journal › Article
- 2019
-
Mark
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
(
- Contribution to journal › Article
- 2018
-
Mark
Complement C4d-specific antibodies for the diagnosis of lung cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
(
- Contribution to journal › Article
-
Mark
New perspectives on complement mediated immunotherapy
(
- Contribution to journal › Scientific review
-
Mark
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.
(
- Contribution to journal › Article
- 2013
-
Mark
Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies.
(
- Contribution to journal › Scientific review